Showing results (51-60 of 1,191) with videos related to
Sort By:
Pageof 120
La Nouvelle Presse Medicale|May 13, 1978
[Whited Addison's disease. Eight cases (author's transl)]P Vague, R Combes, E Altomare, et al.Diabetes & Metabolism|April 2, 2005
Factors related to CSII complianceO Ronsin, M F Jannot-Lamotte, P Vague, et al.Diabete & Metabolisme|February 1, 1987
Cold reacting antilymphocyte antibodies in type I (insulin dependent) diabetesB Vialettes, P Mercier, P De Micco, et al.Acta Diabetologica Latina|October 1, 1985
Sustained initial remission induced by intensive insulin treatment in type I diabetes. Possible role of the genetic backgroundP Vague, B Vialettes, V Lassmann, et al.Bulletin De L'Academie Nationale De Medecine|June 5, 1998
[Genetic factors, Na K ATPase activity and neuropathy in diabetics]P Vague, D Dufayet, M F Lamotte, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|August 1, 1994
Modulation defect of sodium pump evidenced in diabetic patients by a microcalorimetric studyT Issautier, H Kovacic, P Gallice, et al.Presse Medicale (Paris, France : 1983)|April 19, 1997
[Nutrition in patients treated with antilipemic agents. Survey of 337 patients]M C Bernard, J F Renucci, N Tosello, et al.The American Journal of Medicine|May 7, 1999
Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramineM Apfelbaum, P Vague, O Ziegler, et al.Journal of Clinical & Laboratory Immunology|January 1, 1983
Assessment of viral and immune factors in EMC virus-induced diabetes: effects of cyclosporin A and interferonB Vialettes, D Baume, C Charpin, et al.Metabolism: Clinical and Experimental|September 1, 1989
Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese womenP Vague, I Juhan-Vague, V Chabert, et al.Pageof 120